메뉴 건너뛰기




Volumn 98, Issue 6, 2009, Pages 345-352

Hotline sessions presented at the American college of cardiology congress 2009

Author keywords

Aboard; Active a; Admire HF; Armyda recapture; Aurora; Early acs; Encore; Eprotirome; Fix hf 5; Heinz Nixdorf recall study; Horizons ami; Hypoxia inducible factor 1 ; Jupiter; Naples II; Omega; Pre relax ahf; Prima; Reverse; Revival 3; Stich; Tips

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ATORVASTATIN; C REACTIVE PROTEIN; EPTIFIBATIDE; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; RELAXIN; ROSUVASTATIN;

EID: 67651174313     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-009-0023-3     Document Type: Article
Times cited : (6)

References (13)
  • 1
    • 64349095030 scopus 로고    scopus 로고
    • Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): A phase II, double-blind, randomised trial
    • Indian Polycap Study (TIPS). 9672
    • Indian Polycap Study (TIPS) S Yusuf P Pais R Afzal D Xavier K Teo J Eikelboom A Sigamani V Mohan R Gupta N Thomas 2009 Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial Lancet 373 9672 1341 1351
    • (2009) Lancet , vol.373 , pp. 1341-1351
    • Yusuf, S.1    Pais, P.2    Afzal, R.3    Xavier, D.4    Teo, K.5    Eikelboom, J.6    Sigamani, A.7    Mohan, V.8    Gupta, R.9    Thomas, N.10
  • 2
    • 52949139748 scopus 로고    scopus 로고
    • A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics
    • 4
    • WT Abraham D Burkhoff K Nademanee P Carson R Bourge KA Ellenbogen M Parides A Kadish 2008 A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics Am Heart J 156 4 641 648e1
    • (2008) Am Heart J , vol.156
    • Abraham, W.T.1    Burkhoff, D.2    Nademanee, K.3    Carson, P.4    Bourge, R.5    Ellenbogen, K.A.6    Parides, M.7    Kadish, A.8
  • 7
    • 58849098394 scopus 로고    scopus 로고
    • Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association
    • 1
    • H Mollmann H Nef M Bohm U Laufs 2009 Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association Clin Res Cardiol 98 1 1 7
    • (2009) Clin Res Cardiol , vol.98 , pp. 1-7
    • Mollmann, H.1    Nef, H.2    Bohm, M.3    Laufs, U.4
  • 8
    • 33846594268 scopus 로고    scopus 로고
    • A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes
    • 1
    • G Ndrepepa S Braun J Mehilli K Niemoller A Schomig A Kastrati 2007 A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes Clin Res Cardiol 96 1 30 37
    • (2007) Clin Res Cardiol , vol.96 , pp. 30-37
    • Ndrepepa, G.1    Braun, S.2    Mehilli, J.3    Niemoller, K.4    Schomig, A.5    Kastrati, A.6
  • 10
    • 33749389486 scopus 로고    scopus 로고
    • Omega-3 fatty acids in secondary prevention after myocardial infarct
    • Suppl 6
    • H Rupp 2006 Omega-3 fatty acids in secondary prevention after myocardial infarct Clin Res Cardiol 95 Suppl 6 VI12 VI16
    • (2006) Clin Res Cardiol , vol.95
    • Rupp, H.1
  • 13
    • 33749387181 scopus 로고    scopus 로고
    • Significance of changes in habits followed by risk reduction
    • Suppl 6
    • H Voller 2006 Significance of changes in habits followed by risk reduction Clin Res Cardiol 95 Suppl 6 VI6 VI11
    • (2006) Clin Res Cardiol , vol.95
    • Voller, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.